Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: Development and in vitro antitumor activity on human myeloid leukaemia cells

Journal of Biomedical Nanotechnology

Volumn 6, Issue 3, 2010, Pages 214-223

  Ourique, A F ^a   Azoubel, S ^b   Ferreira, C V ^b   Silva, C B ^a   Marchiori, M C L ^a   Pohlmann, A R ^c   Guterres, S S ^c   Beck, R C R ^c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antitumor activity; Leukaemia; Lipid core nanocapsules; Photostability; Retinoic acid; Tretinoin

Indexed keywords

ANTI-TUMOR ACTIVITIES; LEUKAEMIA; PHOTO-STABILITY; RETINOIC ACIDS; TRETINOIN;

MEDICAL NANOTECHNOLOGY; ULTRAVIOLET RADIATION;

NANOCAPSULES;

NANOCAPSULE; POLYMER; RETINOIC ACID; ANTINEOPLASTIC AGENT; LIPID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; LEUKEMIA CELL; MYELOID LEUKEMIA; NANOENCAPSULATION; NANOMEDICINE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROMYELOCYTIC LEUKEMIA; ULTRAVIOLET A RADIATION; ULTRAVIOLET C RADIATION; ZETA POTENTIAL; CELL STRAIN HL 60; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; METHODOLOGY;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG COMPOUNDING; DRUG STABILITY; HL-60 CELLS; HUMANS; LIPIDS; NANOCAPSULES; TRETINOIN;

EID: 79952202607     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2010.1120     Document Type: Article

References (37)

1. Y. Maeda, T. Yamaguchi, Y. Hijikata, M. Tanaka, C. Hirase, S. Takai, Y. Morita, T. Sano, J. Miyatake, Y. Tatsumi, and A. Kanamaru, Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia. J. Cancer Res. Clin. Oncol. 134, 673 (2008).
2. R. B. Geller and S. P. Dix, Oral chemotherapy agents in the treatment of leukaemia. Drugs 58, 109 (1999).
3. P. C. Adamson, H. C. Pitot, F. M. Balis, J. Rubin, R. F. Murphy, and D. G. Poplack, Variability in the oral bioavailability of all-transretinoic acid. J. Natl. Cancer Inst. 85, 993 (1993).
4. J. Muindi, S. R. Frankel, Jr., W. H. Miller, A. Jakubowski, D. A. Scheinberg, C. W. Young, E. Dmitrovsky, Jr., and R. P. Warrell, Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid " resistance" in patients with acute promyelocytic leukemia. Blood 79, 299 (1992).
5. S. R. Hwang, S. Lim, J. Park, and C. Kim, Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm. 276, 175 (2004).
6. G. Zuccari, R. Carosio, A. Fini, P. G. Montaldo, and I. Orienti, Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. J. Control. Release 103, 369 (2005).
7. M. J. Alonso, Nanomedicines for overcoming biological barriers. Biomed. Pharmacother. 58, 168 (2004).
8. J. M. Fachinetto, A. F. Ourique, G. Lubini, S. B. Tedesco, A. C. F. Silva, and R. C. R. Beck, Tretinoin-loaded polymeric nanocapsules: Evaluation of the potential to improve the antiproliferative activities on Allium cepa root-tip compared to the free drug. Lat. Am. J. Pharm. 27, 668 (2008).
9. J. S. Almeida, L. Jezur, M. C. Fontana, K. Paese, C. B. Silva, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Oil-based nanoparticles containing alternative vegetable oils (grape seed oil and almond kernel oil): Preparation and characterization. Lat. Am. J. Pharmacy 28, 165 (2009).
10. M. C. Fontana, K. Coradini, S. S. Guterres, A. R. Pohlmann, and R. C. R. Beck, Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: Influence of the nanostructured system. J. Biomed. Nanotechnol. 5, 1 (2009).
11. P. P. Constantinides, M. V. Chaubal, and R. Shorr, Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv. Drug Deliver. Rev. 60, 757 (2008).
12. J. E. Kipp, The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 284, 109 (2004).
13. S. A. Wissing, O. Kayser, and R. H. Müller, Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliver. Rev. 56, 1257 (2004).
14. M. D. Joshi and R. H. Müller, Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm. 71, 161 (2009).
15. B. Ozpolat, G. Lopez-Berestein, P. Adamson, C. J. Fu, and A. H. Williams, Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J. Pharm. Pharm. Sci. 6, 292 (2003).
16. S. Kawakami, P. Opanasopit, M. Yokoyama, N. Chansri, T. Yamamoto, T. Okano, F. Yamashita, and M. Hashida, Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration. J. Pharm. Sci. 94, 2606 (2005).
17. H. S. Lin, C. S. Chean, Y. Y. Ng, S. Y. Chan, and P. C. Ho, 2-Hydroxypropyl-β-cyclodextrin increases aqueous solubility and photostability of all-trans retinoic acid. J. Clin. Pharm. Then 25, 265 (2000).
18. N. Chansri, S. Kawakami, M. Yokoyama, T. Yamamoto, P. Charoensit, and M. Hashida, Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice. Pharmaceut. Res. 25, 2 (2008).
19. G. Zuccari, V. Bergamante, R. Carasio, R. Gotti, P. G. Montaldo, and I. Orienti, Micellar complexes of all-trans retinoic acid with polyvinylalcohol- nicotinoyl esters as new parenteral formulations in neuroblastoma. Drug Deliv. 16, 189 (2009).
20. S. S. Soppimath, T. M. Aminabhavi, A. R. K. Kulkami, and W. E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70, 1 (2001).
21. A. Jager, V. Stefani, S. S. Guterres, and A. R. Pohlmann, Physicolchemical characterization of nanocapsule polymeric wall using fluorescent benvavole probes. Int. J. Pharm. 338, 297 (2007).
22. C. Vauthier and K. Bouchemal, Methods for the preparation and manufacture of polymeric nanoparticles. Pharmaceut. Res. 26, 5 (2009).
23. E. Jager, C. G. Venturini, F. S. Poletto, L. M. Colomé, J. P. U. Pohlmann, A. Bernardi, A. M. O. Battastini, S. S. Guterres, and A. R. Pohlamnn, Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J. Biomed. Nanotechnol. 5, 130 (2009).
24. V. B. Cattani, L. A. Fiel, A. Jäger, E. Jäger, L. M. Colomé, F. Uchoa, V. Stefani, T. D. Costa, S. S. Guterres, and A. R. Pohlmann, Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs. Eur. J. Pharm. Sci. 39, 116 (2010).
25. A. F. Ourique, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Int. J. Pharm. 352, 1 (2008).
26. A. R. Pohlmann, G. Mezzalira, C. D. G. Venturini, L. Cruz, A. Bernardi, E. Jäger, A. M. O. Battastini, N. Pesce da Silveira, and S. S. Guterres, Determining the simultaneous presence of drug nano-crystals in drug-loaded polymeric nanocapsule aqueous suspensions: A relation between light scattering and drug content. Int. J. Pharm. 359, 288 (2008).
27. H. Fessi, F. Puisieux, and J. P. Devissaguet, Procede de préparation dês systèmes coloïdaux d'une substance sous forme de nanocapsules. European Patent 0274961 Al (1988).
28. M. G. Brisaert, I. Everaerts, and J. A. Plaizier-Vercammen, Chemical stability of tretinoin in dermatological preparations. Pharm. Acta Helv. 70, 161 (1995).
29. S. Uzunoglu, R. Uslu, M. Tobu, G. Saydam, E. Terzioglu, F. Buyukkececi, and S. B. Omay, Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leukemia Res. 23, 507 (1999).
30. A. C. S. Souza, L. Kodach, F. R. Gadelha, C. L. Bos, A. D. M. Cavagis, H. Aoyama, M. P. Peppelenbosch, and C. V. Ferreira, A promising action of ribloflavin as a mediator of leukaemia cell death. Apoptosis 11, 1761 (2006).
31. J. Kohroki, N. Muto, T. Tanaka, N. Itoh, A. Inada, and K. Tanaka, Induction of differentiation and apoptosis by dithizone in human myeloid leukemia cell lines. Leukemia Res. 22, 405 (1998).
32. P. Calvo, J. L. Vila-Jato, and M. J. Alonso, Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules and nanoemulsions, as ocular drug carrier. J. Pharm. Sci. 85, 530 (1996).
33. M. C. Fontana, K. Coradini, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Nanocapsules prepared from amorphous polyesters: Effect on the physicochemical characteristics, drug release and photostability. J. Nanosci. Nanolechnol. 10, 3091 (2010).
34. B. M. Tashtoush, E. L. Jacobson, and M. K. Jacobson, UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations. Int. J. Pharm. 352, 123 (2008).
35. Y. Li, A. Lafuente, and M. A. Trush, Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: Induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity. Life Sci. 54, 901 (1994).
36. M. Orlandi, B. Mantovani, K. Ammar, E. Avitabile, P. Dal Monte, and G. Bartolini, Retinoids and cancer Antitumoral effects of ATRA, 9-cis RA and the new retinoin IIF on the HL-60 leukemic cell line. Med. Princ. Pract. 12, 164 (2003).
37. T. Mossmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55 (1983).